129 related articles for article (PubMed ID: 37163067)
1. Lesion-specific suppression of YAP/TAZ by biomimetic nanodrug ameliorates atherosclerosis development.
Huang HC; Wang TY; Rousseau J; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
bioRxiv; 2023 Apr; ():. PubMed ID: 37163067
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.
Huang HC; Wang TY; Rousseau J; Orlando M; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
Biomaterials; 2024 Apr; 306():122505. PubMed ID: 38359507
[TBL] [Abstract][Full Text] [Related]
3. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
4. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.
Wang L; Luo JY; Li B; Tian XY; Chen LJ; Huang Y; Liu J; Deng D; Lau CW; Wan S; Ai D; Mak KK; Tong KK; Kwan KM; Wang N; Chiu JJ; Zhu Y; Huang Y
Nature; 2016 Dec; 540(7634):579-582. PubMed ID: 27926730
[TBL] [Abstract][Full Text] [Related]
5. Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner.
Hasegawa T; Sugihara T; Hoshino Y; Tarumoto R; Matsuki Y; Kanda T; Takata T; Nagahara T; Matono T; Isomoto H
Oncol Lett; 2021 Oct; 22(4):703. PubMed ID: 34457058
[TBL] [Abstract][Full Text] [Related]
6. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
[TBL] [Abstract][Full Text] [Related]
7. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response.
Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H
Front Immunol; 2021; 12():791907. PubMed ID: 34956224
[TBL] [Abstract][Full Text] [Related]
8. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
Front Physiol; 2021; 12():732084. PubMed ID: 34650444
[TBL] [Abstract][Full Text] [Related]
9. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
Li Y; Yang S; Yang S
Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes.
Yang Y; Pei K; Zhang Q; Wang D; Feng H; Du Z; Zhang C; Gao Z; Yang W; Wu J; Li Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158779. PubMed ID: 32739616
[TBL] [Abstract][Full Text] [Related]
12. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases.
Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y
Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712
[TBL] [Abstract][Full Text] [Related]
14. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation.
Cho K; Ro SW; Lee HW; Moon H; Han S; Kim HR; Ahn SH; Park JY; Kim DY
Hepatology; 2021 Nov; 74(5):2605-2621. PubMed ID: 34101869
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis.
Mohseni R; Alavian SM; Sadeghabadi ZA; Heiat M
Mol Biol Rep; 2021 Jan; 48(1):117-126. PubMed ID: 33296068
[TBL] [Abstract][Full Text] [Related]
17. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts.
Gao N; Lu L; Ma X; Liu Z; Yang S; Han G
Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]